Cargando…
Comparison of two different folic acid doses with methotrexate – a randomized controlled trial (FOLVARI Study)
INTRODUCTION: There is reasonable evidence that folic acid 5–10 mg per week leads to reduction in methotrexate (MTX) toxicity in rheumatoid arthritis (RA). However, this is based on studies conducted with lower MTX dosage than used currently. It is unclear whether higher doses of folic acid may be b...
Autores principales: | Dhir, Varun, Sandhu, Amit, Kaur, Jasbinder, Pinto, Benzeeta, Kumar, Phani, Kaur, Prabhdeep, Gupta, Nidhi, Sood, Ankita, Sharma, Aman, Sharma, Shefali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4483203/ https://www.ncbi.nlm.nih.gov/pubmed/26063325 http://dx.doi.org/10.1186/s13075-015-0668-4 |
Ejemplares similares
-
Low Serum Levels of Myeloid Progenitor Inhibitory Factor-1 Predict Good Response to Methotrexate in Rheumatoid Arthritis
por: Dhir, Varun, et al.
Publicado: (2013) -
Comparison of two doses of leucovorin in severe low-dose methotrexate toxicity – a randomized controlled trial
por: Bhargava, Mudit, et al.
Publicado: (2023) -
Comparison between methotrexate and apremilast in Psoriatic Arthritis-a single blind randomized controlled trial (APREMEPsA study)
por: Samanta, Joydeep, et al.
Publicado: (2023) -
Predictors of COVID-19 severity and outcomes in Indian patients with rheumatic diseases: a prospective cohort study
por: Mathew, Jithin, et al.
Publicado: (2023) -
Correlation between Cut-off Level of Tissue Transglutaminase Antibody and Marsh Classification
por: Kaur, Sumeet, et al.
Publicado: (2017)